Etanercept
اتانرسپت
🎗️ Antineoplastic And Immunomodulating AgentsTNF blocker
Market / country: 🇺🇸 USA
Enbrel (US)
🧮 Dose calculator
Rheumatoid arthritis · Regimen source: FDA Enbrel · 2
🛡️ Safety & information
Contraindications
- ⛔ Sepsis. FDA Enbrel · 4
Warnings
- • Boxed warning: serious infections (TB, fungal, opportunistic) and malignancy. Test for latent TB before starting and treat if positive. FDA Enbrel · Boxed Warning
Formulations
- 50 mg/mL prefilled syringe or autoinjector — injection 🇺🇸 USA FDA Enbrel · 3
- 25 mg/0.5 mL single-dose vial — injection 🇺🇸 USA FDA Enbrel · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label: available studies do not reliably support an association with major birth defects. FDA Enbrel · 8.1
“Available studies with use of etanercept during pregnancy do not reliably support an association between etanercept and major birth defects.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Enbrel · 8.2
“Risk Summary Data from published literature show that etanercept is present in low levels in human milk but is not detected in the plasma of breastfed infants (see Data ) .”
- 👶 ChildrenUse with caution
Label: established for pJIA from 2 y; boxed warning of lymphoma and malignancy in children and adolescents. FDA Enbrel · 8.4
“The safety and effectiveness of Enbrel have been established in pediatric patients 2 years of age and older with pJIA.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Enbrel · 8.5
“Because there is a higher incidence of infections in the elderly population in general, caution should be used in treating the elderly.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)BLA103795
- DailyMed (FDA label)FDA Enbrel
- MedlinePlus (NIH)Etanercept Injection
- WHO ATC/DDDL04AB01
- Darooyab (Iran)Etanercept
🇮🇷 Registered in Iran Darooyab · G-68/Etanercept
Dosage forms with Iranian generic codes, per Darooyab.
- 04008 · ETANERCEPT 25MG VIAL · ویال اتانرسپت ۲۵ میلیگرم
- 21559 · ETANERCEPT 50MG PREFILLED SYRINGE · سرنگ از پیش پرشده اتانرسپت ۵۰ میلیگرم
- 08170 · ETANERCEPT 50MG VIAL · ویال اتانرسپت ۵۰ میلیگرم
- 52294 · ETANERCEPT INJECTION, SOLUTION SUBCUTANEOUS 25 mg/0.5mL · فرآورده تزریقی اتانرسپت ۲۵ میلیگرم / ۰٫۵ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Enbrel · 3FDA Enbrel · 2FDA Enbrel · 2.4FDA Enbrel · 4FDA Enbrel · Boxed WarningFDA Enbrel · SPL approval / marketing categoryFDA Enbrel · 8.1FDA Enbrel · 8.2FDA Enbrel · 8.4FDA Enbrel · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-68/Etanercept
- Clinical review⚠ Unverified